EcoDrugPlus

Phosphodiesterase 4b

Ensembl ID : ENSDLAG00005025655
Gene Symbol: PDE4B
1 Cross references
226 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSDLAG00005021973
Gene Symbol: PDE4D
1 Cross references
222 Possible Orthologues:

Phosphodiesterase 5a, Cgmp-Specific, B

Ensembl ID : ENSDLAG00005020232
Gene Symbol: PDE5AB
1 Cross references
208 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSDLAG00005002083
Gene Symbol: PDE7A
1 Cross references
215 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSDLAG00005005237
Gene Symbol: PIK3R1
1 Cross references
203 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSDLAG00005009702
Gene Symbol: PIK3R3
1 Cross references
188 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSDLAG00005001818
Gene Symbol: PIK3R5
1 Cross references
202 Possible Orthologues:

Phosphoinositide-3-Kinase, Regulatory Subunit 2 (Beta)

Ensembl ID : ENSDLAG00005003340
Gene Symbol: PIK3R2
1 Cross references
190 Possible Orthologues:

Phospholipase A2 Group X

Ensembl ID : ENSDLAG00005015342
Gene Symbol: PLA2G10
1 Cross references
233 Possible Orthologues:

Plasminogen

Ensembl ID : ENSDLAG00005008261
Gene Symbol: PLG
1 Cross references
255 Possible Orthologues:

Platelet-Derived Growth Factor Receptor, Beta Polypeptide

Ensembl ID : ENSDLAG00005008065
Gene Symbol: PDGFRB
1 Cross references
199 Possible Orthologues:

Poly (Adp-Ribose) Polymerase 2

Ensembl ID : ENSDLAG00005002830
Gene Symbol: PARP2
1 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).